Disintegrin and Metalloprotease 17 (ADAM17) was identified as a novel important regulator of necroptosis whose activity could significantly affect the role of TNFR1-dependent tumor cell induction of endothelial cell death, tumor cell extravasation, and subsequent metastatic seeding (114). The gene discussed is ADAM17; the disease is neoplasm.